The evidence is mixed3 supporting, 3 against, 0 worth knowing
Supporting
trading 9% above its 200-day average
matches consistently growing and profitable, which has beaten the market by +0.51 points over 20 sessions across 117,484 past signals
revenue grew 51% year on year in the quarter ending 30 June 2026
Against
down 1% over twelve months
1 of the scans it matches has historically underperformed the market
net margin has narrowed from 44.4% to 26.8% across four quarters
Worth knowing
nothing the data supports either way
What would change this read: a close below 1,325, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working3
Revenue +50.6% year on year, Rs 22 cr to Rs 33 cr.
+50.6%Rs 22 crRs 33 cr
Trading 8.9% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+8.9%
Turned up over three months while the year is still negative.
+12.1% 3M-1.0% 1Y
Needs watching4
Profit growth was -29.0% while revenue growth was +50.6%.
-29.0%+50.6%
Net margin moved from 56.9% to 26.8%.
56.9%26.8%
Net profit -29.0% year on year, Rs 13 cr to Rs 9 cr.
-29.0%Rs 13 crRs 9 cr
Only Rs 2.5 crore changes hands on a median day. A large order moves this price by itself.
Rs 2.5 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 1 of these 4 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
3 of 47 matched on 10 Sep
3BBLACKBIO matches 3 of the 47 scans today, across 2 different kinds of evidence.
3BBLACKBIO trades at 22× trailing earnings, above its median of 18× over this window — 21% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Analyst call filings were typically +0.11pt vs the market over the next 5 sessions (n=4,339) · Results filings were typically -0.51pt vs the market over the next 5 sessions (n=7,726) · Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 51% against the same quarter a year earlier
Going against it
profit dropped 29% year on year
net margin narrowed from 27.7% to 26.8%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
33
13
9
10.48
26.8%
Q4 FY26
31 Mar · consolidated
35
15
10
11.44
27.7%
Q3 FY26
31 Dec · consolidated
50
27
22
26.19
44.6%
Q2 FY26
30 Sep · consolidated
34
20
15
17.55
44.4%
Q1 FY26
30 Jun · consolidated
22
16
13
14.76
56.9%
Q4 FY25
31 Mar · consolidated
22
13
8
9.38
35.7%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+13.0%
Versus 200-day average+8.9%
Below 52-week high-14.9%
Above 52-week low+30.9%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)70.7
Higher closes in last 52 of 5
Six-month return+18.78%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)5.71%
Volume versus 20-day0.6x
Median daily turnoverRs 2.5 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.